News | March 06, 2014

Gore Excluder Iliac Branch Stent Graft Gains European Approval

Gore Excluder AAA Stent Graft

March 6, 2014 — W. L. Gore & Associates’ Gore Excluder Iliac Branch Endoprosthesis is a complete, fully engineered system intended for endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms. It received CE marking. The first patient procedures in Europe were successfully completed by vascular surgeons Piergiorgio Cao, M.D., chief of vascular surgery at San Camillo Hospital, Rome, Italy, Mo Hamady, M.D., consultant interventional radiologist at St. Mary’s Hospital, London, and Michael Jenkins, consultant vascular surgeon and clinical lead at St. Mary’s Hospital, London.

This device is used in conjunction with Gore Excluder AAA Endoprosthesis components to isolate the common iliac artery from systemic blood flow and preserve blood flow in the external iliac and internal iliac arteries. It is built on Gore’s technology platform and designed using the same durable, expanded polytetrafluoroethylene (ePTFE) graft.

“Gore’s dedicated components for iliac artery repair provide the first complete low profile system for managing common iliac artery aneurysms. The procedure is simple and straightforward due to the pre-cannulated branch and bi-femoral delivery system,” Hamady said.

“In endovascular procedures involving iliac arteries, this device is easy to handle and repositionable for precise placement. The Gore Excluder Device based design also provides a wide treatment range and long-term durability, which is extremely important for optimal success,” Cao said. “Additionally, the low profile delivery provides for enhanced vessel access, benefiting patients and physicians alike.”

The Gore Excluder Iliac Branch Endoprosthesis system provides a treatment range of 6.5-13.5 mm for the internal iliac arteries, and a treatment range of 6.5-25 mm for the external iliac arteries. The delivery profile of the loaded catheter allows the use of a 16 F introducer sheath for the iliac branch component, and a 12 F flexible, reinforced introducer sheath for the internal iliac component.

For more information: visitwww.goremedical.com


Related Content

News | Stent Grafts
May 4, 2022 – Seeking to bolster its development of a biocompatible graft that promises to reshape the future of cardiac ...
Home May 04, 2022
Home
News | Stent Grafts

October 9, 2019 — Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and Drug ...

Home October 09, 2019
Home
News | Stent Grafts

October 8, 2019 — PQ Bypass Inc. announced it has received full approval of its investigational device exemption (IDE) ...

Home October 08, 2019
Home
News | Stent Grafts

July 10, 2019 — W. L. Gore & Associates Inc. (Gore) announced the first U.S. implant of the Gore Tag Conformable ...

Home July 10, 2019
Home
Technology | Stent Grafts

May 15, 2019 — W. L. Gore & Associates Inc. (Gore) announced the U.S. Food and Drug Administration (FDA) has granted ...

Home May 15, 2019
Home
News | Stent Grafts

February 14, 2019 — Abdominal aortic stent grafts will remain the largest segment in the global aortic stent graft ...

Home February 14, 2019
Home
Technology | Stent Grafts

February 7, 2019 — Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for the Valiant ...

Home February 07, 2019
Home
News | Stent Grafts

January 7, 2019 — Endologix Inc. announced that in order to ensure optimal outcomes for patients, unrestricted sales and ...

Home January 07, 2019
Home
News | Stent Grafts

July 16, 2018 — Endologix Inc. announced one-year results from the LUCY (Evaluation of FemaLes who are Underrepresented ...

Home July 16, 2018
Home
News | Stent Grafts

June 13, 2018 — Cardinal Health announced that its Incraft Abdominal Aortic Aneurysm (AAA) Stent Graft System has ...

Home June 13, 2018
Home
Subscribe Now